DrugPatentWatch Database Preview
Nexus Pharms Company Profile
What is the competitive landscape for NEXUS PHARMS, and what generic and branded alternatives to NEXUS PHARMS drugs are available?
NEXUS PHARMS has five approved drugs.
Summary for Nexus Pharms
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Nexus Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nexus Pharms | PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | INJECTABLE;INJECTION | 206332-001 | Oct 13, 2017 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Nexus Pharms | ISOPROTERENOL HYDROCHLORIDE | isoproterenol hydrochloride | INJECTABLE;INJECTION | 206961-001 | Aug 2, 2017 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Nexus Pharms | TESTOSTERONE ENANTHATE | testosterone enanthate | INJECTABLE;INJECTION | 040575-001 | Jun 14, 2006 | AO | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Nexus Pharms | COLISTIMETHATE SODIUM | colistimethate sodium | INJECTABLE;INJECTION | 065177-001 | Mar 19, 2004 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Nexus Pharms | SODIUM NITROPRUSSIDE | sodium nitroprusside | INJECTABLE;INJECTION | 207499-001 | May 25, 2017 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Nexus Pharms | PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | INJECTABLE;INJECTION | 206332-002 | Oct 13, 2017 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
